News
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
Onco-Innovations Limited to transfer listing of Common Shares to Cboe Canada from CSE; trading on Cboe Canada begins on May 22, 2025. Company aims for investor trust, liquidity, and visibility under existing ticker symbol 'ONCO' -
-
-
COMMUNIQUÉ DE PRESSE
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering
Apimeds Pharmaceuticals US, Inc. closes IPO with 3,375,000 shares at $4.00 per share. Proceeds to fund clinical trials and product manufacturing -
-
-
-
COMMUNIQUÉ DE PRESSE
Modalités de mise à disposition des documents préparatoires à l'AG
Mise à disposition des informations relatives à l’Assemblée Générale Annuelle Mixte du 06 juin 2025 de Latecoere. Informations disponibles sur le site internet de Latecoere et au siège social. Avis de convocation à venir -
